New stock news | Jiangxi Bioport stock IPO and domestic unlisted shares "fully circulating" approved by the China Securities Regulatory Commission.

Zhtng Cijng APP learned that on April 30, the International Cooperation Department of the China Securities Regulatory Commission issued the "Notice of Filing for Overseas Issuance and Listing of Jiangxi Biological Products Research Institute Co., Ltd. and Full Circulation of Unlisted Shares Domestically". The company plans to issue up to 104,321,500 shares of ordinary shares for overseas listing and listing on the Hong Kong Stock Exchange. 47 shareholders of the company intend to convert a total of 270,855,819 shares of domestically unlisted shares into overseas listed shares and list them for trading on the Hong Kong Stock Exchange.